Yunxi Zheng

No ORCID on file · 11 papers in corpus · active 2017-2025

Study types

  • article 9
  • preprint 2

Condition tags

  • endometriosis 11
  • die_deep_infiltrating 3
  • mesh:D004715 3
  • bowel_endometriosis 2
  • dysmenorrhea 1
  • dyspareunia 1
  • infertility 1
  • endometrioma 1
  • adenomyosis 1
article 2025
Heliyon ·doi:10.1016/j.heliyon.2024.e41543

Introduction: Pregnancy is a special time during which some benign hormonally-responsive lesions could grow and mimic malignancy on clinical evaluation and imaging. Though decidualization of ovarian endometrioma has been reported, little is…

preprint 2024
·doi:10.2139/ssrn.4974517
article 2024
Endoscopy ·doi:10.1055/a-2440-6251
article 2023
European radiology ·doi:10.1007/s00330-023-09795-7

OBJECTIVE: To evaluate MRI features of bowel endometriosis (BE) and verify its clinical significance compared with pathological diagnosis. MATERIALS AND METHODS: Since 2018, patients clinically diagnosed with deep endometriosis (DE) and pla…

article 2023
Contemporary clinical trials communications ·doi:10.1016/j.conctc.2023.101179

Background: Endometriosis is a common benign gynecological disorder with high risk of recurrence and adverse impact on fertility-sparing. This study aims to evaluate the effectiveness and safety of SanJieZhenTong Capsules, a traditional Chi…

preprint 2023
·doi:10.2139/ssrn.4428801
article 2022
BMC women's health ·doi:10.1186/s12905-022-01666-5

BACKGROUND: This study aimed to summarize and analyze clinical characteristics and reproductive outcomes in postoperative deep infiltrating endometriosis (DIE). METHODS: This retrospective cohort study included 55 reproductive-aged patients…

article 2021
·doi:10.4103/2096-2924.313687

Abstract Objective: To compare the efficacy of the traditional Chinese medicine SanJieZhenTong (SJZT) capsules versus gonadotropin-releasing hormone analogs (GnRHa) or oral contraceptives (OCs) in the postoperative treatment of moderate-to-…

article 2020
·doi:10.3760/cma.j.cn101441-20190827-00380

As a new high-potency progesterone and the first drug for endometriosis, dienogest has been used in overseas markets for 11 years, accumulating relevant experience in efficacy and safety. This article reviewed the application of dienogest i…

article 2019
·doi:10.4103/2096-2924.274543

Objective: To investigate factors that may be associated with the recurrence of deep infiltrating endometriosis (DIE) and DIE-related symptoms. Methods: Starting in September 2014, women with a confirmed diagnosis of DIE based on surgical a…

article 2017
The Journal of international medical research ·doi:10.1177/0300060517728208

Objective This study was performed to identify risk factors for postoperative rectovaginal fistula (PRF) in patients with deep infiltrating endometriosis (DIE). Methods Data were retrospectively obtained from the medical records of 104 pati…